RECALL: Next Recalls Younger Boys Navy Brogue Shoes Due To 'Restricted Substance' (Item Code: 964786)

RECALL: Next Recalls Younger Boys Navy Brogue Shoes Due To 'Restricted Substance' (Item Code: 964786)

UK retailer Next has recalled a pair of boys’ shoes because of "a potential problem" with the lining. The shoes contain a restricted substance, benzidine, which can increase the risk of cancer if in prolonged contact with the skin.

The Independent reports:

High street retailer Next is recalling a pair of children’s shoes after they were found to contain a potentially harmful substance which might cause cancer. The retail giant published a statement asking for customers to return ‘Younger Boys Navy Brogue’ shoes after they were found to contain a a quantity of a “restricted substance” which exceeds the group’s specifications. The Australian Competition & Consumer Commission, a product safety body in Australia, on Wednesday confirmed that the hazard referred to by Next is benzidine, a man-made chemical used in fabric and leather dyes.

A statement posted on the Product Recall and Safety Notice Information section of the Next.co.uk website states:

Unfortunately, it's come to light that there's a potential problem with the lining of the above style which contains a quantity of restricted substance which exceeds Next’s specification.

As the shoes don't meet our strict, technical specifications, we've taken the decision of recalling them, and are requesting that you return them to us for a full refund.

Please call us on 0333 777 8185 to arrange a collection, or return the shoes to your local store, if this would suit you better. If you have given this item as a gift, please ask the recipient to contact Next.

We’re very sorry for any disappointment and inconvenience caused, but we hope you’ll understand that customer safety is our highest priority.

Have you bought these shoes?

Sign up for our newsletter

Get more deals from Playpennies with our daily newsletter

By clicking "sign up", you confirm that you agree to our privacy policy & consent to receiving marketing emails.

Comments

Reply to